Advertisement

Cancer Pain pp 11-32 | Cite as

Oral and Parenteral Drug Therapy for Cancer Pain

  • Richard Payne
Part of the Current Management of Pain book series (CUMP, volume 3)

Abstract

Pain in the cancer patient is often a consequence of tumor infiltration or compression of bone, soft tissue, peripheral nerve or spinal cord, or vascular occlusion [4,17]. The most effective management of cancer pain involves treatment of the tumor with surgery, radiation therapy, or chemotherapy, if possible. However, it is often necessary to manage pain with analgesic drugs prior to the introduction of specific antitumor therapy. Moreover, a significant percentage of patients will have chronic pain as a sequela of cancer treatment [42] (see table 1–1, Chapter 1, this volume). Finally, although invasive neurosurgical and anesthetic approaches to cancer pain management are indicated in a minority of patients, with a few exceptions (e.g., celiac ganglion blocks for pancreatic pain) they are not first-line treatments [16]. Therefore, the use of analgesic drugs has become the mainstay of acute and chronic cancer pain management, and narcotic analgesics are the drugs of choice for management of severe pain [4,15,55].

Keywords

Cancer Pain Postherpetic Neuralgia Narcotic Analgesic Cancer Pain Management Chronic Cancer Pain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Amer S, Amer B (1985): Differential effects of epidural morphine in the treatment of cancer-related pain. Acta Anaesthesiol Scand 29: 32–36.Google Scholar
  2. 2.
    Beaver WT, Feise G (1976): Comparison of the analgesic effects of morphine, hydroxyzine and their combination in patients with post-operative pain. In: Bonica JJ, Albe-Fessard D (eds), Advances in Pain Research and Therapy. New York: Raven Press, pp 553–557.Google Scholar
  3. 3.
    Beaver WT, Wallenstein SL, Houde RW, et al. (1966): A comparison of the analgesic effect of methotrimeprazinc and morphine in patients with cancer. Clin Pharmacol Ther 7: 436–446.PubMedGoogle Scholar
  4. 4.
    Bonica, JJ (1985): The treatment of cancer pain: current status and future needs. In: Fields HL et al. (eds), Advances in Pain Research and Therapy, vol 9. New York: Raven Press, pp 589–616.Google Scholar
  5. 5.
    Botney M, Fields HL (1983): Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann Neurol 13: 160–164.PubMedCrossRefGoogle Scholar
  6. 6.
    Brogden RN, Speigt TM, Avery GS (1973): Pentazocine: a review of pharmacological properties, therapeutics, efficacy and dependence. Drugs 5: 6–91.PubMedCrossRefGoogle Scholar
  7. 7.
    Bromage PR (1985): Clinical aspects of intrathecal and epidural opiates. In: Fields HL et al. (eds), Advances in Pain Research and Therapy, vol 9. New York: Raven Press, pp 733–748.Google Scholar
  8. 8.
    Campbell CF, Matson JB, Weiler JM (1983): Continuous subcutaneous infusion of morphine for the pain of terminal malignancy. Ann Int Med 98: 51–52.PubMedGoogle Scholar
  9. 9.
    Chauvin M, Samii K, Schermann JM, et al. (1982): Plasma pharmacokinetics of morphine after i.m., extradural and intrathecal administration. Br J Anaesth 54: 843–848.PubMedCrossRefGoogle Scholar
  10. 10.
    Cleeland CS, Cleeland LM, Dar R, et al. (1986): Factors in influencing physician management of cancer pain. Cancer 58: 796–800.PubMedCrossRefGoogle Scholar
  11. 11.
    Cousins MJ, Mather LE (1984): Intrathecal and epidural administration of opioids. Anesthesiology 61: 276–310.PubMedCrossRefGoogle Scholar
  12. 12.
    Coyle N, Mauskop A, Maggard J, et al. (1986): Continuous subcutaneous infusion of opiates in cancer patients with pain. One Nurs Forum 13: 53–57.Google Scholar
  13. 13.
    Feinmann C (1985): Pain relief by antidepressants: possible modes of action. Pain 23: 1–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Foley, KM (1981): Current issues in the management of cancer pain: Memorial Sloan-Kettering Cancer Center. In: Loreng NG (ed), New Approaches to Treatment of Chronic Pain. Nida Research Monograph 36: 169–181.Google Scholar
  15. 15.
    Foley KM (1982): The practical use of narcotic analgesics. Med Clin North Am 66: 1091–1104.PubMedGoogle Scholar
  16. 16.
    Foley, KM, Sundaresan N (1984): Management of cancer pain. In: Devita VT, Hellman S, Rosenberg SA (eds), Cancer: Principles and Practice of Oncology. Philadelphia: J.B. Lippincott Co., pp 1941–1961.Google Scholar
  17. 17.
    Foley KM (1985): The treatment of cancer pain. N Engl J Med 313: 84–95.PubMedCrossRefGoogle Scholar
  18. 18.
    Foley KM (1985): Adjuvant analgesic drugs in cancer pain management. In: Aronoff GM (ed), Evaluation and Treatment of Chronic Pain. Baltimore-Munich: Urban and Schwarzenberg.Google Scholar
  19. 19.
    Forrest WH, Brown BW, Brown CR, et al. (1977): Dextroamphetamine with morphine for the treatment of postoperative pain. N Engl J Med 296: 712–715.PubMedCrossRefGoogle Scholar
  20. 20.
    Fraser DG (1980): Intravenous morphine infusion for chronic pain. Ann lot Med 93: 781–782.Google Scholar
  21. 21.
    Graves D, Foster TS. Batenhorst RL, et al. (1983): Patient-controlled analgesia. Ann Int Med 99:360–366.Google Scholar
  22. 22.
    Greenberg HS, Taren J, Ensminger WD, Doan K (1982): Benefit from and tolerance to containuous intrathecal infusion of morphine for intractable cancer pain. J Neurosurg 57: 360–364.PubMedCrossRefGoogle Scholar
  23. 23.
    Harris LS (1979): Cannabinoids as analgesics. In: Beers RF, Bassett EG (eds), New York: Raven Press. Mechanism of Pain and Analgesic Compounds.Google Scholar
  24. 24.
    Houde RW (1974): The use and misuse of narcotics in the treatment of chronic pain. Adv Neurol 4: 527–536.Google Scholar
  25. 25.
    Inturrisi CE, Max MB, Foley KM, et al. (1984): The pharmacokinetics of heroin in patients with chronic pain. N Engl J Med 210: 1213–1217.CrossRefGoogle Scholar
  26. 26.
    Kaiko RF, Wallenstein SL, Rogers AG, et al. (1981): Analgesic and mood effects of heroin and morphine in cancer patients with postoperative pain. N Engl J Med 304: 1501–1505.PubMedCrossRefGoogle Scholar
  27. 27.
    Kaiko RF, Wallenstein SL, Rogers AG, et al. (1982): Narcotics in the elderly. Med Clin North Am 66: 1079–1089.PubMedGoogle Scholar
  28. 28.
    Kaiko RF, Foley KM, Grabinski PY, et al. (1983): Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 13: 180–185.PubMedCrossRefGoogle Scholar
  29. 29.
    Kanner RM, Foley KM (1981): Patterns of narcotic drug use in a cancer pain clinic. Ann NY Acad Sci 362: 161–172.PubMedCrossRefGoogle Scholar
  30. 30.
    Kantor TG (1982): The control of pain by nonsteroidal anti-inflammatory drugs. Med Clin North Am 66: 1053–1059.PubMedGoogle Scholar
  31. 31.
    King JS, Gallant P, Myerson V, et al. (1976): The effects of anti-inflammatory agents on the responses and the sensitization of unmyelinated (C) fiber polymodal receptors. In: Zotterman Y (ed), Sensory Function of the Skin of Primates. Oxford: Pergamon Press, pp 441–461.Google Scholar
  32. 32.
    Leavens ME, Hill CS, Cech DA, et al. (1982): Intrathecal and intraventricular morphine for pain in cancer patients: initial study. J Neurosurg 56: 241–242.PubMedCrossRefGoogle Scholar
  33. 33.
    Lenzi A, Galli G, Gandolfini M, et al. (1985): Intraventricular morphine in paraneoplastic painful syndrome of the cervicofacial region: experience in thirty-eight cases. Neurosurgery 17: 6–11.PubMedCrossRefGoogle Scholar
  34. 34.
    Levin D, Cleeland CS, Dar R (1985): Public attitudes toward cancer pain. Cancer 56: 2337–2339.PubMedCrossRefGoogle Scholar
  35. 35.
    Lobato RD, Madrid JL, Fatela LV, et al. (1985): Analgesia elicited by low-dose intraventricular morphine in terminal cancer patients. In: Fields HL et al. (eds), Advances in Pain Research and Therapy, vol 9. New York: Raven Press, pp 673–681.Google Scholar
  36. 36.
    Max MB, Inturrisi CE, Kaiko RF, et al. (1985): Epidural and intrathecal opiates: cerebrospinal fluid and plasma profiles in patients with chronic cancer pain. Clin Pharmacol Ther 38: 631–641.PubMedCrossRefGoogle Scholar
  37. 37.
    Miser AW, Davis DM, Hughes CS, et al. (1983): Continuous subcutaneous infusions of morphine in children with cancer. Am J Dis Child 137: 383–385.PubMedGoogle Scholar
  38. 38.
    Miser AW, Miser JS, Clark BS (1980): Continuous intravenous infusion of morphine sulfate for control of severe pain in children with terminal malignancy. J Pediatr 5: 930–932.Google Scholar
  39. 39.
    Nahata MC, Miser AW, Miser JS, et al. (1984): Analgesic plasma concentrations of morphine in children with terminal malignancy receiving a continuous subcutaneous infusion of morphine sulfate to control severe pain. Pain 18: 109–114.PubMedCrossRefGoogle Scholar
  40. 40.
    Neis A, Robinson DS, Friedman MJ, et al. (1977): Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiat 134: 790–793.Google Scholar
  41. 41.
    Newman RG (1983): The need to redefine “addiction”. N Engl J Med 308: 1096–1098.PubMedCrossRefGoogle Scholar
  42. 42.
    Payne R, Foley KM (1984): Advances in the management of cancer pain. Cancer Treat Rep 68: 173–83.PubMedGoogle Scholar
  43. 43.
    Payne R (1986): The role of spinal opiates and opioid peptides in the management of cancer pain. Med Clin North Am (in press).Google Scholar
  44. 44.
    Perry S, Heidrich G (1982): Management of pain during debridement: a survey of U.S. burn units. Pain 13: 267–280.PubMedCrossRefGoogle Scholar
  45. 45.
    Porter J, Jick H (1980): Addiction rare in patients treated with narcotics. N Engl J Med 302: 133.Google Scholar
  46. 46.
    Portenoy RK, Moulin DE, Rogers A, et al. (1986): I.V. infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treat Rep 70: 575–581.PubMedGoogle Scholar
  47. 47.
    Roquefeuil B, Benezech J, Blanchet P, et al. (1984): Intraventricular administration of morphine in patients with neoplastic intractable pain. Surg Neurol 21: 155–158.PubMedCrossRefGoogle Scholar
  48. 48.
    Rotstein J, Good RA (1957): Steroid pseudorheumatism. Arch Int Med 99: 545–555.Google Scholar
  49. 49.
    Schlechter NE (1985): Pain and pain control in children. Curr Prob Pediatr 15: 1–67.Google Scholar
  50. 50.
    Spiegel K, Kalb R, Pasternak GW (1983): Analgesic activity of tricyclic antidepressants. Ann Neurol 13: 462–465.PubMedCrossRefGoogle Scholar
  51. 51.
    Swerdlow M (1984): Anticonvulsant drugs and chronic pain. Clin Neuropharmacol 7: 51–82.PubMedCrossRefGoogle Scholar
  52. 52.
    Tameson A, Hartvig P, Fagerlund C, et al. (1982): Patient-controlled analgesia: clinical experience. Acta Anesthesiol Scand (Suppl) 14: 157–160.CrossRefGoogle Scholar
  53. 53.
    Twycross RG (1977): Value of cocaine in opiate-containing elixirs. Br Med J 2: 1348.PubMedCrossRefGoogle Scholar
  54. 54.
    Twycross RG (1977): Choice of strong analgesic in terminal cancer: diamorphine or morphine? Pain 3: 93–104.PubMedCrossRefGoogle Scholar
  55. 55.
    Twycross RG, Lack SA (1983): Symptom Control in Far Advanced Cancer: Pain Relief. London: Pitman Publishing.Google Scholar
  56. 56.
    Ventafridda V, Spoldi E, Caraceni A, et al. (1986): The importance of continuous subcutaneous morphine administration for cancer pain. The Pain Clinic 1: 47–55.Google Scholar
  57. 57.
    Waldmann CS, Eason JR, Rambohul E, et al. (1984): Serum morphine levels. A comparison between continuous subcutaneous infusion and continuous intravenous infusion in postoperative patients. Anaesthesia 39: 768–771.PubMedCrossRefGoogle Scholar
  58. 58.
    Watson CP, Evans RJ, Reid K, et al. (1982): Amitriptyline vs. placebo in postherpetic neuralgia. Neurology 32: 671–73.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers, Boston 1989

Authors and Affiliations

  • Richard Payne

There are no affiliations available

Personalised recommendations